GlobeNewswire Inc | Oct 28, 2020 06:00AM EDT

October 28, 2020

Replicating the Successful Duramed Model as in New York and New Jersey

HICKSVILLE, NY, Oct. 28, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp. (OTCQB:CANB)(Can B or the Company),adiversified health and wellness company, is pleased to announce its expansion for itsDuramedDivision ultrasound program, the SAM Pro 2.0, to Michigan.The revolutionary Sustained Acoustic Medicine (SAM) wellness solutiois proven in[aa1]accelerating tissue healing and chronic pain reduction and is reimbursable by health insurance companies.

This marks the first availability of Duramed beyond its initial success in New York and New Jersey. The opening of Michigan was made possible for no fault insurance via an agreement with Allcare Practice Management.

The SAM Pro 2.0 is the first and only FDA cleared wearable low intensity ultrasound device delivering multi-hour treatment to accelerate healing and improve function for musculoskeletal injuries (muscle, tendon, ligament) and reduce chronic pain (without opioid pain medication).

Durameds marketing strategy is to provide equipment and services to both medical offices as well as direct to consumer. The recurring revenue business model calls for a rental rate per day, which is billed to the insurance company.

Duramedis a member of MAGNACARE, an industry organization that insures expedient processing (1st check within 30 days) + arbitration/negotiation support.

Marco Alfonsi, Can Bs Chief Executive Officer, commented, We are thrilled in achieving this milestone of expanding upon our success in New York and New Jersey with this revolutionary solution that addresses a much needed void in the market to accelerate tissue healing and chronic pain reduction. The unique SAM delivery system, recurring revenue business model and our potential to add our proprietary CBD gels, is expected drive our acceleration of revenue at improved gross margins over the next twelve months.

AboutCan B Corp.

Can B Corp. (OTCQB:CANB) is a Health & Wellness company providing the highest quality cannabidiol (CBD) products under the brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. CanB is also an exclusive partner of the LifeGuard Brand in developing a line of consumer products. The Company is also launching Super Foods, a line of nutritional supplements. Can B Corp. owns and operates an R&D and production facility in Lacey, WA and Green Grow Farms, a licensed hemp grow and cultivation in New York.To learn more about Can B Corp. and our comprehensive line of high quality CBD products, please visit:Canbiola.comandwww.CanBCorp.com, follow Can B Corp onInstagramandFacebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.

For more information about Can B Corp., please visit:CanBCorp.com

Twitter @CanBCorp

Instagram @canbcorp

Facebook @ Can B Corp

Forward-Looking Statements

Forward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Investors and Media:

IR@canbiola.com

(917) 658-7878